Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: US
  • Asset Class: Equity
  • Geographic Focus: U.S.

Natixis International Funds Lux I - Loomis Sayles US Research

+ Add to Watchlist

CDCUSRI:LX

217.30 USD 0.44 0.20%

As of 09:16:00 ET on 04/29/2015.

Snapshot for Natixis International Funds Lux I - Loomis Sayles US Research (CDCUSRI)

Year To Date: +3.31% 3-Month: +5.31% 3-Year: +14.10% 52-Week Range: 191.27 - 219.83
1-Month: +1.40% 1-Year: +10.78% 5-Year: +12.96% Beta vs SPTR: 1.01

Mutual Fund Chart for CDCUSRI

No chart data available.
  • CDCUSRI:LX 217.30
  • 1M
  • 1Y
Interactive CDCUSRI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CDCUSRI

Natixis International Funds (Lux) I - Loomis Sayles US Research is an open-end Fund incorporated in Luxembourg. The Fund's objective is a maximum total return and long-term capital growth. The Fund invests at least 2/3 of its assets in US equity securities of large-capitalisation companies.

Inception Date: 06-20-2001 Telephone: +352-474-066-312
Managers: MAUREEN DEPP
Web Site: ga.natixis.com/global

Fundamentals for CDCUSRI

NAV (on 2015-04-29) 217.30
Assets (M) (on 2015-04-29) 713.43
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment -

Dividends for CDCUSRI

No dividends reported

Fees & Expenses for CDCUSRI

Front Load 4.00
Back Load 0.00
Current Mgmt Fee -
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.00

Top Fund Holdings for CDCUSRI

Filing Date: 02/27/2015
Name Position Value % of Total
Apple Inc 190,413 24,460,454 3.427%
Gilead Sciences Inc 201,004 20,809,944 2.915%
Actavis plc 54,347 15,834,542 2.218%
Visa Inc 231,264 15,686,059 2.197%
Exxon Mobil Corp 168,722 14,938,646 2.093%
Google Inc 26,522 14,922,073 2.090%
Google Inc 26,448 14,728,358 2.063%
Wells Fargo & Co 260,070 14,249,235 1.996%
JPMorgan Chase & Co 224,143 13,735,483 1.924%
UnitedHealth Group Inc 120,210 13,659,462 1.914%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil